# MSH Pharma Inc. – FDA Inspection, Aug 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/msh-pharma-inc/d6f34195-7138-48fd-92dd-14e6843c74ec
Source feed: FDA_Inspections

> FDA inspection 1250816 of MSH Pharma Inc., August 23, 2024. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250816
- Company Name: MSH Pharma Inc.
- Inspection Date: 2024-08-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1042573 - 2018-01-10
- FDA Inspection 812932 - 2012-12-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/msh-pharma-inc/f9e7cd4a-6172-45a1-9743-3d331a79b46b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c